- AU$159.92m
- AU$150.65m
- AU$111.52m
- 79
- 48
- 99
- 87
Annual cashflow statement for SomnoMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.016 | 0.011 | 0.007 | 0.03 | 0.023 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.71 | 1.86 | -3.88 | -6.33 | 7.78 |
| Capital Expenditures | -4.13 | -8.79 | -6.41 | -5.34 | -3.98 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.236 | 0.317 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -4.37 | -8.47 | -6.41 | -5.34 | -3.98 |
| Financing Cash Flow Items | 0 | — | 0 | -2.07 | -0.044 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.8 | 2.09 | 6.61 | 16.7 | -3.38 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.06 | -5.47 | -3.69 | 4.22 | 1.11 |